Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Philippe Prouet"'
Publikováno v:
Blood Advances, Vol 1, Iss 12, Pp 779-791 (2017)
Abstract: Hemophagocytic lymphohistiocytosis (HLH) is a syndrome of cytokine-driven immune activation. Cardinal features include fever, hemophagocytosis, hepatosplenomegaly, lymphocytic infiltration, and hypercytokinemia that result in multisystem or
Externí odkaz:
https://doaj.org/article/b291f1b4b56648c2b0fbd112feb19983
Autor:
Kruti Patel, Sophia S. Lee, Poojitha Valasareddy, Namratha R. Vontela, Philippe Prouet, Mike G. Martin
Publikováno v:
Blood Advances, Vol 1, Iss 3, Pp 205-207 (2016)
Externí odkaz:
https://doaj.org/article/732db3c16c65450393addc3b69b530d3
Publikováno v:
JCO precision oncology. 3
Publikováno v:
JCO Precision Oncology. :1-3
Autor:
Jeremiah L. Deneve, George Yaghmour, Philippe Prouet, Michael Gary Martin, Paxton V. Dickson, Smith Giri, Martin D. Fleming, Elena P. Lamb, Eric Wiedower, Jason C. Chandler, Andrew Fintel
Publikováno v:
Anticancer Research. 37:813-818
BACKGROUND We evaluated surgical trends for gastric diffuse large B-cell lymphoma (gDLBCL) before and after the approval of rituximab and whether an association of early mortality existed in patients treated after approval of rituximab. PATIENTS AND
Hemophagocytic lymphohistiocytosis (HLH) is a syndrome of cytokine-driven immune activation. Cardinal features include fever, hemophagocytosis, hepatosplenomegaly, lymphocytic infiltration, and hypercytokinemia that result in multisystem organ dysfun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6afd0a8c5b011ff2e5f0b74157e0af80
https://europepmc.org/articles/PMC5728056/
https://europepmc.org/articles/PMC5728056/
Autor:
Jason Porter, Adriana Hepner, Manjari Pandey, Philippe Prouet, Felicia Hare, Syed S. Nasir, Madison Boles, Henrik Zetterberg, Kaj Blennow, Michael Martin
Publikováno v:
Cancer Research. 79:1352-1352
Introduction: While the morbidity and mortality attributable to gliomas and brain metastases is significant, there are currently no approved biomarkers for detecting and monitoring intracranial disease and imaging remains the primary modality. Blood
Autor:
Danny Yakoub, Richard M. Goldberg, Michael Gary Martin, Axel Grothey, Paxton V. Dickson, Jimmy J. Hwang, Evan S. Glazer, W. Michael Korn, David Shibata, Anthony F. Shields, Matthew K Stein, Philippe Prouet, Joanne Xiu, Jeffrey Owsley, Forrest W Williard, Jeremiah L. Deneve, Heinz-Josef Lenz
Publikováno v:
Journal of Clinical Oncology. 37:4053-4053
4053 Background: PM from GC or GEJ portend a poor prognosis and molecular differences are ill defined. Methods: We compared genomic profiles of primary (P) GC and GEJ with PM patients (pts) and other metastases (OM) sent to Caris Life Sciences. Testi
Autor:
Madison Boles, Jason Porter, Michael Gary Martin, Henrik Zetterberg, Syed Sameer Nasir, Philippe Prouet, Manjari Pandey, Felicia Hare
Publikováno v:
Journal of Clinical Oncology. 36:e24028-e24028
e24028Background: Currently there are no serum biomarkers associated with activity of cancer in the brain. We hypothesized that sNfL would correlate with the activity of either BM or G. Methods: sN...
Publikováno v:
Blood reviews. 30(1)
Acute megakaryocytic leukemia (AMegL) is a biologically heterogenous subtype of acute myeloid leukemia (AML) that arises from megakaryocytes. Improvements in the accuracy of diagnosing AMegL as well as interest in the molecular analysis of leukemias